eStoreRx™
Online Supplement Dispensary
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
eStoreRx™ is an easy direct-to-patient ordering & fulfilment program for lifelong wellness.
Biotics Research is proud to expand our commitment to education with the Wellness Unfiltered Pro Podcast. Each episode delves into key health topics and the clinical applications of our premier products. Through candid, insightful conversations, our team offers practical guidance to keep you informed and empowered as a healthcare professional.
December 20 2024
The British Journal of Sports Medicine recently published a systematic review that analyzed the effects of postpartum exercise on maternal postpartum ...
Vitamin D is probably most known for its association with bone health, but a recent study suggests higher levels of vitamin D in the bloodstream may have a protective role against colorectal malignancy. In this study, the people who had lower levels of vitamin D had a 31 percent higher risk of colorectal malignancy, and those with higher levels of circulating 25(OH)D had a 22 percent lower risk.
The study included 17 cohorts, comprised of 5706 colorectal cancer patients and 7107 control subjects, all with a wide range of circulating 25(OH)D levels. The varying vitamin D levels were categorized based on what is currently recommended by the Institute of Medicine (IOM), based on bone health.
“Compared with the lower range of sufficiency for bone health (50–<62.5 nmol/L), deficient 25(OH)D (<30 nmol/L) was associated with 31% higher colorectal cancer risk (RR = 1.31, 95% confidence interval [CI] = 1.05 to 1.62); 25(OH)D above sufficiency (75–<87.5 and 87.5–<100 nmol/L) was associated with 19% higher colorectal cancer risk (RR = 0.81, 95% CI = 0.67 to 0.99) and 27% (RR = 0.73, 95% CI = 0.59 to 0.91) lower risk, respectively. Associations were minimally affected when adjusting for body mass index, physical activity, or other risk factors.
In conclusion, for each 25 nmol/L increments of circulating 25(OH)D, colorectal cancer risk was decreased 19% in women (RR = 0.81, 95% CI = 0.75 to 0.87) and 7% in men (RR = 0.93, 95% CI = 0.86 to 1.00). It appears that the optimal 25(OH)D concentrations associated with reducing colorectal cancer risk would be 75-100 nmol/L, higher than what is currently recommended by IOM for bone health.
Ref.: McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang W-Y, Jenab M, Jones ME, Joshu CE, Krogh V, Lee I-M, Lee JE, Männistö S, Le Marchand L, Monduln AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun S-S, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts. JNCI: Journal of the National Cancer Institute, djy087, https://doi.org/10.1093/jnci/djy087
Submit this form and you'll receive our latest news and updates.
A systematic review and meta-analysis recently published in the Journal of the Academy of Nutrition and Dietetics examin...
Learn moreA recent study has shown that out of 120 women with polycystic ovary syndrome (PCOS), the majority showed low levels of ...
Learn moreAn intriguing study found different effects on pregnant mice’s liver metabolism as a result of vitamin D deficiency (VDD...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment